Nasal lymphoma: Results of local radiotherapy with or without chemotherapy

Head and Neck

Volumn 19, Issue 4, 1997, Pages 251-259

  Yu, Kwok Hung ^a   Yu, Simon C H ^a   Teo, Peter M L ^a   Chan, Anthony T C ^a   Yeo, Winnie ^a   Chow, John ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chemotherapy; Nasal lymphoma; Radiotherapy

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; HIGH RISK PATIENT; HISTOLOGY; HUMAN; LYMPHOMA; NOSE CANCER; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 0030980760     PISSN: 01486403     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0347(199707)19:4<251::aid-hed2>3.0.co;2-%23     Document Type: Article

References (20)

1. Mill WB, Lee FA, Franssila KO. Radiation therapy treatment of stage I and II extranodal non-Hodgkin's lymphoma of the head and neck. Cancer 1980;45:653-661.
2. Ferry JA, Sklar J, Zukerbery LR, et al. Nasal lymphoma: a clinicopathologic study with immunophenotypic and genotypic analysis. Am J Surg Pathol 1991;15:268-279.
3. Senan S, Symonds RP, Brown IL. Nasal peripheral T-cell lymphoma: a 20-year review of cases treated in Scotland. Clin Oncol 1992;4:96-100.
4. Itami J, Itami M, Mikata A, et al. Non-Hodgkin's lymphoma confined to the nasal cavity: its relationship to the polymorphic reticulosis and results of radiation therapy. Int J Radiat Oncol Biol Phys 1991;20:797-802.
5. Liang R, Todd D, Chan TK, et al. Nasal lymphoma: a retrospective analysis of 60 cases. Cancer 1990;66: 2205-2209.
6. Liang R, Todd D, Chan TK, et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol 1995;13:666-670.
7. Yamanaka N, Harabuchi Y, Sambe S, et al. Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity: clinical and immunologic aspects. Cancer 1985;56: 768-776.
8. Shigematsu N, Kondo M, Mikata A. Prognostic factors of stage I and II non-Hodgkin's lymphomas of the head and neck: the value of the Working Formulation and need for chemotherapy. Int J Radiat Oncol Biol Phys 1988;15: 1111-1118.
9. Ye YL, Zhou MH, Lu XY, et al. Nasopharyngeal and nasal malignant lymphoma: a clinicopathological study of 54 cases. Histopathology 1992;20:511-516.
10. Stansfeld AG, Diebold J, Kapanci Y, et al. Updated Kiel classification for lymphomas. Lancet 1988;1:292-293.
11. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971;31:1860-1861.
12. Robbins KT, Fuller LM, Vlasak M, et al. Primary lymphomas of the nasal cavity and paranasal sinuses. Cancer 1985;56:814-819.
13. Schein PS, DeVita VT, Hubbard S, et al. Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. Ann Intern Med 1976;85:417-422.
14. McKelvey EM, Gottlieb JA, Wilson HE, et al. Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer 1976;38:1484-1493.
15. Fisher RI, DeVita VT, Hubbard SM, et al. Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of ProMACE and MOPP chemotherapy. Ann Intern Med 1983;98:304-309.
16. Shipp MA, Harrington DP, Klatt MM, et al. Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD. Ann Intern Med 1986;104:757-765.
17. Cabanillas F, Hagemeister FB, Bodey GP, et al. IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. Blood 1982;60:693-697.
18. Ho JHC. Nasopharynx. In: Halnan KE, ed. Treatment of cancer. New York: Igaku-Shoin, 1982:249-268.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-482.
20. Perez CA, Brady LW. Overview. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology, 2nd ed. Philadelphia: JB Lippincott, 1992:51-53.